Search Results
School of Women’s & Children’s Health, Discipline of Obstetrics and Gynaecology, University of New South Wales, Sydney, Australia
Search for other papers by David Mark Robertson in
Google Scholar
PubMed
Search for other papers by Chel Hee Lee in
Google Scholar
PubMed
Search for other papers by Angela Baerwald in
Google Scholar
PubMed
of rat follicle-stimulating hormone release than inhibin a in vitro and in vivo . Endocrinology 2009 150 4784 – 4793 . ( doi:10.1210/en.2008-1783 ) 9 Bédécarrats GY O’Neill FH Norwitz ER Kaiser UB Teixeira J. Regulation
Search for other papers by Lian Hollander-Cohen in
Google Scholar
PubMed
Search for other papers by Benjamin Böhm in
Google Scholar
PubMed
Search for other papers by Krist Hausken in
Google Scholar
PubMed
Search for other papers by Berta Levavi-Sivan in
Google Scholar
PubMed
brain culminate in a signal to the pituitary gland to release the gonadotropins (GTHs). The pituitary GTHs include follicle-stimulating hormone (FSH) and luteinizing hormone (LH), and together are responsible for gametogenesis, steroidogenesis, protein
Search for other papers by Agnieszka Adamska in
Google Scholar
PubMed
Search for other papers by Paulina Tomczuk-Bobik in
Google Scholar
PubMed
Search for other papers by Anna Beata Popławska-Kita in
Google Scholar
PubMed
Search for other papers by Katarzyna Siewko in
Google Scholar
PubMed
Search for other papers by Angelika Buczyńska in
Google Scholar
PubMed
Search for other papers by Piotr Szumowski in
Google Scholar
PubMed
Search for other papers by Łukasz Żukowski in
Google Scholar
PubMed
Search for other papers by Janusz Myśliwiec in
Google Scholar
PubMed
Search for other papers by Monika Zbucka-Krętowska in
Google Scholar
PubMed
Search for other papers by Marcin Adamski in
Google Scholar
PubMed
Clinical Research Centre, Medical University of Bialystok, Białystok, Poland
Search for other papers by Adam Jacek Krętowski in
Google Scholar
PubMed
hormonal markers, dynamic tests, and ultrasonographic (USG) parameters, for example, antral follicle count (AFC). Markers such as the serum levels of anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH), or inhibin B are relatively good
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Search for other papers by Nathalie Ly in
Google Scholar
PubMed
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Search for other papers by Sophie Dubreuil in
Google Scholar
PubMed
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Sorbonne University, Paris, France
Search for other papers by Philippe Touraine in
Google Scholar
PubMed
production by corpus luteum ( 2 , 3 , 5 , 7 ), both directly and synergistically with follicle-stimulating hormone (FSH) and human chorionic gonadotrophin (hCG) action. GH also has a role on oocyte quality. In vivo , Mendoza et al. show a positive
Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Setagaya, Tokyo, Japan
Search for other papers by Maki Igarashi in
Google Scholar
PubMed
Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Setagaya, Tokyo, Japan
Search for other papers by Tadayuki Ayabe in
Google Scholar
PubMed
Search for other papers by Kiwako Yamamoto-Hanada in
Google Scholar
PubMed
Search for other papers by Keiko Matsubara in
Google Scholar
PubMed
Search for other papers by Hatoko Sasaki in
Google Scholar
PubMed
Search for other papers by Mayako Saito-Abe in
Google Scholar
PubMed
Search for other papers by Miori Sato in
Google Scholar
PubMed
Search for other papers by Nathan Mise in
Google Scholar
PubMed
Search for other papers by Akihiko Ikegami in
Google Scholar
PubMed
Search for other papers by Masayuki Shimono in
Google Scholar
PubMed
Search for other papers by Reiko Suga in
Google Scholar
PubMed
Research Center for Environment and Developmental Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan
Search for other papers by Shouichi Ohga in
Google Scholar
PubMed
Research Center for Environment and Developmental Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan
Search for other papers by Masafumi Sanefuji in
Google Scholar
PubMed
Search for other papers by Masako Oda in
Google Scholar
PubMed
Search for other papers by Hiroshi Mitsubuchi in
Google Scholar
PubMed
Search for other papers by Takehiro Michikawa in
Google Scholar
PubMed
Search for other papers by Shin Yamazaki in
Google Scholar
PubMed
Search for other papers by Shoji Nakayama in
Google Scholar
PubMed
Search for other papers by Yukihiro Ohya in
Google Scholar
PubMed
Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Setagaya, Tokyo, Japan
Search for other papers by Maki Fukami in
Google Scholar
PubMed
, and DHEA-S were 0.092 pmol/L (0.025 pg/mL), 0.017 nmol/L (5 pg/mL), and 0.14 μmol/L (50 pg/mL), respectively. Serum levels of luteinizing hormone (LH) and follicle stimulating hormone (FSH) were measured using standard chemiluminescent enzyme immune
Search for other papers by Eleftherios E Deiktakis in
Google Scholar
PubMed
Search for other papers by Eleftheria Ieronymaki in
Google Scholar
PubMed
Search for other papers by Peter Zarén in
Google Scholar
PubMed
Search for other papers by Agnes Hagsund in
Google Scholar
PubMed
Search for other papers by Elin Wirestrand in
Google Scholar
PubMed
Search for other papers by Johan Malm in
Google Scholar
PubMed
Search for other papers by Christos Tsatsanis in
Google Scholar
PubMed
Imperial College London, Institute of Reproductive and Developmental Biology, London, UK
Search for other papers by Ilpo T Huhtaniemi in
Google Scholar
PubMed
Malmö University Hospital, Reproductive Medicine Center, Malmö, Sweden
Search for other papers by Aleksander Giwercman in
Google Scholar
PubMed
Search for other papers by Yvonne Lundberg Giwercman in
Google Scholar
PubMed
(LH), a potential caveat is the rebound of follicle-stimulating hormone (FSH) after its initial suppression. In contrast, the recently introduced GnRH antagonists provide permanent suppression of both gonadotropins ( 2 ), which may offer a therapeutic
Search for other papers by M von Wolff in
Google Scholar
PubMed
Laboratory of Biometry, University of Thessaly, Volos, Greece
Search for other papers by C T Nakas in
Google Scholar
PubMed
Division of Pneumology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
Search for other papers by M Tobler in
Google Scholar
PubMed
Search for other papers by T M Merz in
Google Scholar
PubMed
Search for other papers by M P Hilty in
Google Scholar
PubMed
Search for other papers by J D Veldhuis in
Google Scholar
PubMed
Search for other papers by A R Huber in
Google Scholar
PubMed
Search for other papers by J Pichler Hefti in
Google Scholar
PubMed
−80°C thereafter. Cortisol, prolactin, thyroid-stimulating hormone (TSH), free tetraiodothyronine (fT4), free triiodothyronine (fT3), follicle-stimulating hormone (FSH), luteinizing hormone (LH) and total testosterone (testosterone) were analysed
Search for other papers by Mikkel Andreassen in
Google Scholar
PubMed
Search for other papers by Anders Juul in
Google Scholar
PubMed
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Search for other papers by Niels Jørgensen in
Google Scholar
PubMed
Introduction The gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are released from the gonadotropic cells in the anterior pituitary gland. In men, the main target cells for LH are Leydig cells with subsequent
Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China
Search for other papers by Tao Mei in
Google Scholar
PubMed
Search for other papers by Jianhe Zhang in
Google Scholar
PubMed
Search for other papers by Liangfeng Wei in
Google Scholar
PubMed
Search for other papers by Xingfeng Qi in
Google Scholar
PubMed
Search for other papers by Yiming Ma in
Google Scholar
PubMed
Search for other papers by Xianhua Liu in
Google Scholar
PubMed
Search for other papers by Shaohua Chen in
Google Scholar
PubMed
Search for other papers by Songyuan Li in
Google Scholar
PubMed
Search for other papers by Jianwu Wu in
Google Scholar
PubMed
Search for other papers by Shousen Wang in
Google Scholar
PubMed
ages ranged from 18 to 79 years, with an average age of 47.50 ± 13.39 years. According to immunohistochemistry ( 13 ), there were 49 cases of prolactin (PRL), 11 cases of growth hormone (GH), 33 cases of multiple hormone, 42 cases of follicle-stimulating
Search for other papers by Yunting Lin in
Google Scholar
PubMed
Search for other papers by Endi Song in
Google Scholar
PubMed
Search for other papers by Han Jin in
Google Scholar
PubMed
Search for other papers by Yong Jin in
Google Scholar
PubMed
postmenopausal women (with the decrease of E2 level and the increase of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels), the incidence of CVD events significantly increased, becoming similar to that in men ( 21 , 22 ). However, a growing